PE20060529A1 - Metodo para preparar compuestos de pirrolotriazina - Google Patents

Metodo para preparar compuestos de pirrolotriazina

Info

Publication number
PE20060529A1
PE20060529A1 PE2005000761A PE2005000761A PE20060529A1 PE 20060529 A1 PE20060529 A1 PE 20060529A1 PE 2005000761 A PE2005000761 A PE 2005000761A PE 2005000761 A PE2005000761 A PE 2005000761A PE 20060529 A1 PE20060529 A1 PE 20060529A1
Authority
PE
Peru
Prior art keywords
formula
compound
alkyl
compounds
pirrolotry
Prior art date
Application number
PE2005000761A
Other languages
English (en)
Inventor
Zhongping Shi
John Hynes
Luca Parlanti
Stephen T Wrobleski
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20060529A1 publication Critical patent/PE20060529A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

REFERIDA A UN METODO PARA PREPARAR UN COMPUESTO DE FORMULA V, DONDE R1 Y R3 SON H, HALOGENO, CIANO, ENTRE OTROS; X ES O, S, C(=O), ENTRE OTROS; R2 ES H, ALQUILO, S(=O), ENTRE OTROS; R6 ES H, ALQUILO, ALQUINILO, ENTRE OTROS; DONDE DICHO PROCEDIMIENTO SE CARACTERIZA PORQUE COMPRENDE: (a) HACER REACCIONAR UN COMPUESTO DE FORMULA I, DONDE R1, X, R2 Y R3 SE DEFINEN COMO ANTERIORMENTE, Y D ES C(=O)ORp, DONDE Rp ES H, ALQUILO C1-C6 O ARILO; CON UNA BENZOIL HIDROXIL AMINA DE FORMULA III EN PRESENCIA DE UNA BASE, EN DONDE R4 ES H, NITRO, CIANO, ENTRE OTROS, Y n ES 1, 2 O 3; PARA FORMAR UN COMPUESTO DE FORMULA II, DONDE R1, X, R2, R3 Y D SE DEFINEN COMO ANTERIORMENTE; Y (b) HACER REACCIONAR EL COMPUESTO DE FORMULA II CON UNA AMIDA DE FORMULA R6C(=O)NH2, DONDE R6 SE DEFINE COMO ANTERIORMENTE, PARA FORMAR EL COMPUESTO DE FORMULA V. DICHO PROCEDIMIENTO ES UTIL PARA LA PREPARACION DE COMPUESTOS DE PIRROLOTRIAZINA COMO COMPONENTES O PRECURSORES EN LA SINTESIS DE COMPUESTOS ANTICANCERIGENOS E INHIBIDORES DE CINASA
PE2005000761A 2004-06-30 2005-06-30 Metodo para preparar compuestos de pirrolotriazina PE20060529A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58438204P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
PE20060529A1 true PE20060529A1 (es) 2006-06-21

Family

ID=35783307

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000761A PE20060529A1 (es) 2004-06-30 2005-06-30 Metodo para preparar compuestos de pirrolotriazina

Country Status (9)

Country Link
US (1) US7534881B2 (es)
EP (1) EP1765827A4 (es)
JP (1) JP2008505175A (es)
CN (1) CN101010324A (es)
AR (1) AR049561A1 (es)
NO (1) NO20070550L (es)
PE (1) PE20060529A1 (es)
TW (1) TW200600513A (es)
WO (1) WO2006004724A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010379A (es) * 2002-04-23 2005-02-17 Squibb Bristol Myers Co Compuestos de pirrolo-triazina anilina utiles como inhibidores de cinasa.
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US20050288290A1 (en) * 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7504521B2 (en) * 2004-08-05 2009-03-17 Bristol-Myers Squibb Co. Methods for the preparation of pyrrolotriazine compounds
TW200618803A (en) 2004-08-12 2006-06-16 Bristol Myers Squibb Co Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
EP2376491B1 (en) 2008-12-19 2015-03-04 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors
WO2012031057A1 (en) 2010-09-01 2012-03-08 Bristol-Myers Squibb Company Bms- 582949 for the treatment of resistant rheumatic disease
WO2021094209A1 (en) 2019-11-12 2021-05-20 Bayer Aktiengesellschaft Substituted pyrrolo triazine carboxamide derivatives as prostaglandin ep3 receptor antagonists

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118481A (en) * 1995-06-05 2000-08-31 Rhone Poulenc Agrochimie Sulfur compounds pesticidal compositions containing them and method of their application
WO2000071129A1 (en) 1999-05-21 2000-11-30 Bristol-Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
US6906067B2 (en) * 1999-12-28 2005-06-14 Bristol-Myers Squibb Company N-heterocyclic inhibitors of TNF-α expression
US20020065270A1 (en) * 1999-12-28 2002-05-30 Moriarty Kevin Joseph N-heterocyclic inhibitors of TNF-alpha expression
US6867300B2 (en) * 2000-11-17 2005-03-15 Bristol-Myers Squibb Company Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
US6670357B2 (en) * 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
WO2003002544A1 (en) * 2001-06-26 2003-01-09 Bristol-Myers Squibb Company N-heterocyclic inhibitors of tnf-alpha expression
TW200300350A (en) * 2001-11-14 2003-06-01 Bristol Myers Squibb Co C-5 modified indazolylpyrrolotriazines
US7388009B2 (en) * 2002-04-23 2008-06-17 Bristol-Myers Squibb Company Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors
MXPA04010379A (es) * 2002-04-23 2005-02-17 Squibb Bristol Myers Co Compuestos de pirrolo-triazina anilina utiles como inhibidores de cinasa.
DE60325469D1 (de) * 2002-04-23 2009-02-05 Bristol Myers Squibb Co Als kinase inhibitoren geeignete arylketonpyrrolotriazin-verbindungen
TW200400034A (en) * 2002-05-20 2004-01-01 Bristol Myers Squibb Co Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
TWI329112B (en) 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
US6933386B2 (en) * 2002-07-19 2005-08-23 Bristol Myers Squibb Company Process for preparing certain pyrrolotriazine compounds
EP1543009A4 (en) * 2002-08-02 2007-08-08 Bristol Myers Squibb Co Pyrrolotriazine KINASE INHIBITORS
TW200407127A (en) * 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
TW200420565A (en) * 2002-12-13 2004-10-16 Bristol Myers Squibb Co C-6 modified indazolylpyrrolotriazines
EP1590335A4 (en) * 2003-02-05 2006-03-08 Bristol Myers Squibb Co PROCESS FOR THE PRODUCTION OF PYRROLOTRIAZINKINASE INHIBITORS
US7419978B2 (en) * 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
US7102001B2 (en) * 2003-12-12 2006-09-05 Bristol-Myers Squibb Company Process for preparing pyrrolotriazine
MY145634A (en) * 2003-12-29 2012-03-15 Bristol Myers Squibb Co Pyrrolotriazine compounds as kinase inhibitors
US7064203B2 (en) * 2003-12-29 2006-06-20 Bristol Myers Squibb Company Di-substituted pyrrolotriazine compounds
TWI338004B (en) 2004-02-06 2011-03-01 Bristol Myers Squibb Co Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7491725B2 (en) * 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
US7102002B2 (en) * 2004-06-16 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7253167B2 (en) * 2004-06-30 2007-08-07 Bristol-Myers Squibb Company Tricyclic-heteroaryl compounds useful as kinase inhibitors
US7102003B2 (en) * 2004-07-01 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine compounds
US7504521B2 (en) * 2004-08-05 2009-03-17 Bristol-Myers Squibb Co. Methods for the preparation of pyrrolotriazine compounds

Also Published As

Publication number Publication date
TW200600513A (en) 2006-01-01
WO2006004724A2 (en) 2006-01-12
EP1765827A2 (en) 2007-03-28
US20060003967A1 (en) 2006-01-05
NO20070550L (no) 2007-03-26
EP1765827A4 (en) 2009-07-29
AR049561A1 (es) 2006-08-16
CN101010324A (zh) 2007-08-01
US7534881B2 (en) 2009-05-19
JP2008505175A (ja) 2008-02-21
WO2006004724A3 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
PE20060529A1 (es) Metodo para preparar compuestos de pirrolotriazina
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
PE20020061A1 (es) Fenil sulfamoil carboxamidas sustituidas
PE20061335A1 (es) Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c
PE20050131A1 (es) Derivados de benzoimidazol como agentes antiproliferativos
UA93861C2 (uk) Спосіб одержання n-фенілпіразол-1-карбоксамідів та сполука аніліну
PE20010030A1 (es) Compuesto heteroaromatico biciclico
PE20120814A1 (es) Compuestos y composiciones como inhibidores de la proteina cinasa
PE20020514A1 (es) Aminas heterociclicas y fenilazacicloalcanos sustituidos para el tratamiento del sindrome de piernas inquietas
BRPI0513777A (pt) composto ou um sal do mesmo, composição farmacêutica, e, uso de um composto ou de um sal do mesmo
NO20064175L (no) Heterosyklisk forbindelse
PE20061084A1 (es) Compuestos derivados de 2-ciano-3-(halo)alcoxi-bencenosulfonamida
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
SG153811A1 (en) Quinazolinone derivatives useful as vanilloid antagonists
CY1109896T1 (el) Εξω- και διαστερεο- εκλεκτικες συνθεσεις αναλογων της ιμβακινης
PE20060554A1 (es) Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina como inhibidores de la fosfotirosina fosfatasa 1b y procedimientos para su preparacion
PE20071286A1 (es) Composicion para inducir tolerancia viral en plantas
PE20070007A1 (es) Metodos para sintetizar derivados de 6-alquilaminoquinolina
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
MY136824A (en) Substituted benzoxazinones and uses thereof
CY1110145T1 (el) Αλκυλο-υποκατεστημενες ινδολοκινοξαλινες
PE20060734A1 (es) Derivado de pirrol sustituido como antagonistas del receptor de androgenos
PE20040528A1 (es) Inhibidores de la peptido-deformilasa
WO2007070865A3 (en) Piperazine compounds as agonists of trpv4 channel receptors
TW200606154A (en) Mercaptoimidazoles as CCR2 receptor antagonists

Legal Events

Date Code Title Description
FC Refusal